NCT02675205 Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm Status COMPLETED Phase PHASE3
NCT02671461 Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" Status COMPLETED Phase PHASE2
NCT02670304 Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS Status COMPLETED Phase PHASE4
NCT02666742 DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation Status COMPLETED Phase PHASE4
NCT02640794 Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI Status COMPLETED Phase PHASE4
NCT02630862 Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization Status COMPLETED Phase NA
NCT02616497 ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS) Status COMPLETED Phase PHASE4
NCT02607436 Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease Status COMPLETED Phase PHASE4
NCT02565693 Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation Status COMPLETED Phase PHASE2
NCT02548650 Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT02545933 Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor Status COMPLETED Phase PHASE4
NCT02531165 Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Status COMPLETED Phase NA
NCT02521285 Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02497820 Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers Status NOT_YET_RECRUITING Phase PHASE3
NCT02483169 PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study Status UNKNOWN Phase PHASE4